fluorodeoxyglucose f18 has been researched along with Cell Transformation, Neoplastic in 81 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.23) | 18.7374 |
1990's | 3 (3.70) | 18.2507 |
2000's | 17 (20.99) | 29.6817 |
2010's | 55 (67.90) | 24.3611 |
2020's | 5 (6.17) | 2.80 |
Authors | Studies |
---|---|
Devillers, A; Girard, A; Haumont, LA; Lamy, T; Le Jeune, F; Mesbah, H; Palard-Novello, X; Pontoizeau, C; Salaün, PY; Tempescul, A | 1 |
Date, H; Hamaji, M; Murakami, K; Yoshizawa, A | 1 |
Chen, X; Huang, Y; Jiang, Y; Luo, R; Wang, F | 1 |
Bold, MS; Call, TG; Chanan-Khan, AA; Ding, W; Fonder, AL; Hanson, CA; Hayman, SR; Kay, NE; Kenderian, SS; Koehler, AB; Leis, JF; Muchtar, E; Parikh, SA; Rabe, KG; Schwager, SM; Shi, M; Slager, SL; Van Dyke, DL; Wang, Y | 1 |
Tavakoli, S | 1 |
Almonacid-Sánchez, C; Gorospe Sarasúa, L; Jaureguízar-Oriol, A; Rioja-Martín, ME | 1 |
Delmer, A; Dupuis, J; Durot, E; Godet, S; Hivert, B; Ivanoff, S; Kanagaratnam, L; Le Dû, K; Leblond, V; Lemal, R; Leprêtre, S; Merabet, F; Michallet, AS; Morel, P; Perrot, A; Regny, C; Roussel, X; Sutton, L; Tomowiak, C; Toussaint, E; Van Den Neste, E; Zini, JM | 1 |
Abdel-Atti, D; Dilling, TR; Edwards, KJ; Evans, MJ; Henry, KE; Lewis, JS | 1 |
Asano, Y; Fujita, H; Kadono, T; Masui, Y; Miyagawa, T; Saigusa, R; Sato, S; Yamada, D | 1 |
Baech, J; Cheah, CY; El-Galaly, TC; Gormsen, LC; Lo, A; Villa, D | 1 |
Anten, M; Boone, K; Brinkman, M; Jentjens, S; Nelemans, PJ; Stumpel, CTRM; van Kroonenburgh, MJPG | 1 |
Basu, S; Parghane, R | 1 |
Hohaus, S; Lavalle, M; Manfredi, R; Minordi, LM; Rufini, V | 1 |
Bashir, U; Cook, GJ; Goda, JS; Goh, V; Siddique, M; Weeks, A | 1 |
Agrawal, A; Gulia, A; Nayak, P; Purandare, NC; Puranik, A; Puri, A; Rangarajan, V; Rekhi, B; Shah, S | 1 |
Kairemo, K; Subbiah, V; Wang, WL | 1 |
Andersen, KF; Divilov, V; Koziorowski, J; Lewis, JS; Pillarsetty, N | 1 |
Carbonetti, G; Carlin, SD; Chiosis, G; de Stanchina, E; Divilov, V; Gomes-DaGama, EM; Holland, JP; Janjigian, YY; Lewis, JS; Viola-Villegas, N | 1 |
Huang, D; Li, B; Wang, H; Xu, H; Yao, Y; Yu, W; Zhao, X | 1 |
Fukayama, M; Hosoi, A; Kurokawa, M; Nakamura, F; Nakazaki, K; Nannya, Y; Shinozaki-Ushiku, A; Uni, M; Yoshimi, A | 1 |
Blay, JY; Combemale, P; Giammarile, F; Goulart, DM; Guillot, B; Mognetti, T; Pinson, S; Valeyrie-Allanore, L; Wolkenstein, P | 1 |
Borbély, K; Kásler, M; Németh, Z | 1 |
Adib, S; Beauvais, D; Berthon, C; Bonnet, S; Coiteux, V; Decaux, O; Demarquette, H; Facon, T; Fouquet, G; Guidez, S; Herbaux, C; Hivert, B; Huglo, D; Leleu, X; Macro, M; Terriou, L; Van de Wyngaert, Z; Wemeau, M | 1 |
Fujikuni, N; Misumi, T; Ohdan, H; Suzuki, T; Tanabe, K; Tokumoto, N | 1 |
Aboagye, EO; Faber, C; Griffiths, J; Heinzmann, K; Hermann, S; Honess, DJ; Jacobs, AH; Kopka, K; Kuhlmann, MT; Müller-Tidow, C; Schäfers, M; Schelhaas, S; Schneider, R; Schober, O; Smith, DM; Viel, T; Wachsmuth, L; Wagner, S | 1 |
Aung, W; Endo, H; Fujibayashi, Y; Furukawa, T; Hasegawa, S; Inoue, M; Jin, ZH; Saga, T; Yoshii, Y; Yuan, Q; Zhang, MR | 1 |
Cagnolini, A; Gruaz-Guyon, A; Lantry, LE; Montravers, F; Nataf, V; Nunn, AD; Prignon, A; Provost, C; Talbot, JN | 1 |
Chen, P; Huang, Q; Jiang, M; Sun, L; Wu, H | 1 |
Boellaard, R; Chamuleau, ME; Cillessen, SA; Hoekstra, OS; Hoetjes, N; Jauw, Y; Regelink, JC; Rizvi, SN; van de Ven, PM; Wondergem, MJ; Zijlstra, JM; Zweegman, S | 1 |
Davis, G; Hardy, TG; Kurniawan, ED; McKelvie, P | 1 |
Kishida, M; Kondo, K; Miyoshi, H; Nagata, M; Otani, T; Otsuka, H; Takizawa, H | 1 |
Ai, H; Chen, S; Cheng, Z; Jiang, X; Li, X; Lu, H; Qing, H; Wei, R; Wu, C; Xu, G | 1 |
Ishino, S; Miyake, H; Mori, I; Vincent, P | 1 |
Chang, CA; Kumar, B; Nandurkar, D | 1 |
Khashab, T; Medeiros, LJ; Samaniego, F; Sehgal, L | 1 |
Adam, G; Derlin, T; Mautner, VF; Salamon, J | 1 |
Blay, JY; Brahmi, M; Combemale, P; Decouvelaere, AV; Mognetti, T; Pinson, S; Ranchere, D; Renard, C; Thiesse, P | 1 |
Fukushima, S; Hatazawa, J; Ito, E; Kashiyama, N; Kawamura, A; Kawamura, T; Masuda, S; Miyagawa, S; Morii, E; Sawa, Y; Toda, K; Watabe, T | 1 |
Brugières, P; Djelbani-Ahmed, S; Itti, E; Luciani, A; Ortonne, N; Rahmouni, A; Sbidian, E; Valeyrie-Allanore, L; Van Der Gucht, A; Wolkenstein, P; Zehou, O | 1 |
Chen, YR; Hsieh, TC; Hsu, CN; Kao, CH; Kuo, YC | 1 |
Fanfani, F; Ferrandina, G; Gentileschi, S; Mattoli, MV; Palluzzi, E; Pennacchia, I; Scambia, G; Valentini, AL; Zannoni, G | 1 |
Matsuda, M; Sueda, S; Taniguchi, T | 1 |
Gatenby, RA; Gillies, RJ; Robey, I | 1 |
Plathow, C; Weber, WA | 1 |
Berrebi, O; Keller, A; Ratib, O; Rougemont, AL; Steiner, C | 1 |
Aupee, O; Bonardel, G; Foehrenbach, H; Gontier, E; Le Garlantezec, P; Soret, M; Vedrine, L | 1 |
Agarwal, M; Arora, A; Parasar, DS; Purandare, NC; Rangarajan, V; Shah, S; Sharma, AR | 1 |
Costantini, DL; Done, SJ; Fasih, A; Green, DE; McLarty, K; Reilly, RM; Scollard, DA; Vines, DC | 1 |
Ao, Y; Dang, J; Dry, SM; Eilber, FC; Gregorian, C; Lawson, G; Liu, X; Mellinghoff, IK; Mischel, PS; Nakashima, J; Nghiemphu, PL; Parada, LF; Phelps, M; Smith, KB; Sofroniew, MV; Wu, H | 1 |
Abrisqueta, P; Fuertes, S; Fuster, D; Lafuente, S; López-Guillermo, A; Mena, LM; Pons, F; Rodríguez, S; Rubí, S; Setoain, X | 1 |
Aide, N; Denoyer, D; Dorow, DS; Greguric, I; Hicks, RJ; Katsifis, A; Neels, OC; Roselt, P; Taylor, SR | 1 |
Bonenkamp, HJ; de Geus-Oei, LF; de Rooy, JW; Flucke, UE; van de Luijtgaarden, AC; van der Graaf, WT | 1 |
Li, H; Li, W; Liu, Y; Ren, R; Tang, Y; Wei, Z | 1 |
Mahmood, S; Martínez de Llano, SR; Sajid, S | 1 |
Autio, A; Jalkanen, S; Luoto, P; Roivainen, A; Salomäki, S; Ujula, T | 1 |
Aide, N; Bohn, P; Briand, M; Carreiras, F; Chasle, J; Deslandes, E; Dutoit, S; Lasnon, C; Modzelewski, R; Poulain, L; Rouvet, J; Vela, A; Vera, P | 1 |
Asopa, R; Malhotra, G; Rajan, MG | 1 |
Bercich, L; Bertagna, F; Biasiotto, G; Bosio, G; Fisogni, S; Giubbini, R | 1 |
Feustel, PJ; Karam, M; Nazeer, T; Vera, CD | 1 |
Binderup, T; Denholt, CL; Gillings, N; Hansen, PR; Kjær, A; Poulsen, HS; Spang-Thomsen, M; Stockhausen, MT | 1 |
Ito, H; Tahara, E; Toi, M; Yasui, W | 1 |
Hicks, RJ; Hofman, MS | 1 |
Ciarallo, A; Lisbona, R; Makis, W; Novales-Diaz, JA | 1 |
Germanos, MS; Manfredi, MG; Robertson, R; Silva, MD; Smith, PG | 1 |
Kim, CK; Kim, KS; Lee, J; Lee, JD; Yun, M | 1 |
Drubach, L; Fahey, F; Irons, M; Tsai, LL; Ullrich, NJ; Voss, S | 1 |
Henderson, R; Ho, L; Sheth, S; Wassef, H | 1 |
Kato, K; Okada, M; Saga, T; Sudo, H; Sugyo, A; Tsuji, AB; Wakizaka, H; Yoshida, C; Zhang, MR | 1 |
García Vicente, AM; Hernández Ruiz, B; Jiménez Londoño, GA; Soriano Castrejón, Á | 1 |
Graham, MM; Kubo, A; Nishitani, H; Otsuka, H | 1 |
Basu, S; Nair, N | 1 |
Ganju, V; Grigg, A | 1 |
Bruzzi, J; Giles, F; Swords, R | 1 |
Arbuckle, S; Holland, AJ; Howman-Giles, R; Kellie, S; Mihm, D; Montfort, JM | 1 |
Bensaid, B; Combemale, P; Drouet, A; Galoisy-Guibal, L; Giammarile, F; Mognetti, T; Pinson, S | 1 |
Heldmann, M; Lilien, DL; Reddy, MP; Sangster, GP; Takalkar, AM; Zhang, RD | 1 |
Jullien, P; Lawrence, DA | 1 |
Darcourt, J; Lagrange, JL; Maublant, J | 1 |
Bishop, AF; Smith, SM; Young, CS | 1 |
Alger, JR; Bonavita, S; Di Chiro, G; Duyn, JH; Lundbom, N; Raman, R; Tedeschi, G | 1 |
Morakinyo, T; Nguyen, DT | 1 |
12 review(s) available for fluorodeoxyglucose f18 and Cell Transformation, Neoplastic
Article | Year |
---|---|
FDG-PET/CT in the management of lymphomas: current status and future directions.
Topics: Biopsy; Bone Marrow; Cell Transformation, Neoplastic; Disease Progression; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prognosis; Treatment Outcome; Tumor Burden | 2018 |
Evaluation of the most commonly used (semi-)quantitative parameters of 18F-FDG PET/CT to detect malignant transformation of neurofibromas in neurofibromatosis type 1.
Topics: Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Humans; Neurofibromatosis 1; Positron Emission Tomography Computed Tomography | 2018 |
Small Cell Transformation of Metastatic Prostate Adenocarcinoma Diagnosed by Dual-Tracer PET/CT (
Topics: Adenocarcinoma; Aged; Cell Transformation, Neoplastic; Clinical Decision-Making; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Neoplasm Metastasis; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radioactive Tracers; Treatment Outcome | 2019 |
[Clinical application of 18F-FDG PET/CT in the treatment of sarcomas].
Topics: Biopsy; Cell Transformation, Neoplastic; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Multimodal Imaging in Neurofibromatosis Type 1-associated Nerve Sheath Tumors.
Topics: Adult; Cell Transformation, Neoplastic; Child; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Nerve Sheath Neoplasms; Neurofibromatosis 1; Peripheral Nervous System Neoplasms; Positron-Emission Tomography; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging; Young Adult | 2015 |
Endometriosis-associated clear cell carcinoma arising in caesarean section scar: a case report and review of the literature.
Topics: Abdominal Wall; Adenocarcinoma, Clear Cell; Adult; Antibiotics, Antineoplastic; Biopsy, Fine-Needle; Cell Transformation, Neoplastic; Cesarean Section; Cicatrix; Doxorubicin; Endometrial Neoplasms; Endometriosis; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Hysterectomy; Laparoscopy; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoadjuvant Therapy; Ovariectomy; Pelvis; Polyethylene Glycols; Positron Emission Tomography Computed Tomography; Pregnancy; Rectus Abdominis; Salpingectomy | 2016 |
Causes and consequences of increased glucose metabolism of cancers.
Topics: Cell Hypoxia; Cell Transformation, Neoplastic; Evolution, Molecular; Female; Fluorodeoxyglucose F18; Game Theory; Glucose; Glycolysis; History, 19th Century; History, 20th Century; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; Oncogenes; Radionuclide Imaging; Radiopharmaceuticals | 2008 |
Tumor cell metabolism imaging.
Topics: Amino Acids; Animals; Biological Transport; Cell Transformation, Neoplastic; Cellular Structures; Fluorodeoxyglucose F18; Glucose; Humans; Lipid Metabolism; Magnetic Resonance Imaging; Neoplasms; Oncogenes; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |
[Evaluation of therapies in oncology by positron emission tomography: towards therapeutical personalization].
Topics: Cell Count; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Humans; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2009 |
Imaging in follicular NHL.
Topics: Biopsy, Needle; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed | 2011 |
Recent advances in the diagnosis and therapy of Richter's syndrome.
Topics: Antineoplastic Agents; Cell Transformation, Neoplastic; Citrates; Fluorodeoxyglucose F18; Gallium; Gallium Radioisotopes; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Positron-Emission Tomography; Radiopharmaceuticals; Syndrome | 2007 |
[Positron-emission tomography: role of 18F-fluorodeoxyglucose (18FDG) imaging in oncology].
Topics: Cell Transformation, Neoplastic; Deoxyglucose; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gamma Cameras; Humans; Lymphatic Metastasis; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Predictive Value of Tests; Tomography, Emission-Computed | 1995 |
1 trial(s) available for fluorodeoxyglucose f18 and Cell Transformation, Neoplastic
Article | Year |
---|---|
18F-FDG or 3'-deoxy-3'-18F-fluorothymidine to detect transformation of follicular lymphoma.
Topics: Adult; Aged; Area Under Curve; Biomarkers, Tumor; Biopsy; Cell Transformation, Neoplastic; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphoma, Follicular; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Remission Induction; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
68 other study(ies) available for fluorodeoxyglucose f18 and Cell Transformation, Neoplastic
Article | Year |
---|---|
Prognostic Value of Baseline Total Metabolic Tumor Volume Measured on FDG PET in Patients With Richter Syndrome.
Topics: Adult; Aged; Cell Transformation, Neoplastic; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multivariate Analysis; Prognosis; Retrospective Studies; Tumor Burden | 2020 |
Sub-centimeter adenocarcinoma arising from mature mediastinal teratoma during 11 years of follow-up.
Topics: Adenocarcinoma; Cell Transformation, Neoplastic; Chest Tubes; Drainage; Dyspnea; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Mediastinal Neoplasms; Middle Aged; Pleural Effusion; Positron-Emission Tomography; Radiopharmaceuticals; Teratoma; Thoracotomy | 2020 |
Longitudinal observation of solitary fibrous tumor translation into malignant pulmonary artery intimal sarcoma.
Topics: Aged; Bone Neoplasms; Cell Transformation, Neoplastic; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Pulmonary Artery; Sarcoma; Solitary Fibrous Tumors; Tunica Intima; Vascular Neoplasms | 2020 |
The role of 18F-FDG-PET in detecting Richter's transformation of chronic lymphocytic leukemia in patients receiving therapy with a B-cell receptor inhibitor.
Topics: Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Positron-Emission Tomography; Receptors, Antigen, B-Cell | 2020 |
Promises and Challenges of Metabolic Imaging: Where Does
Topics: Animals; Biological Transport; Cell Line, Tumor; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Humans; Macrophages; Mice | 2020 |
Richter Syndrome With Extensive Isolated Pleural Extranodal Involvement: The Importance of PET/CT Imaging.
Topics: Aged; Cell Transformation, Neoplastic; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Syndrome | 2017 |
Transformed Waldenström macroglobulinaemia: clinical presentation and outcome. A multi-institutional retrospective study of 77 cases from the French Innovative Leukemia Organization (FILO).
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Cell Transformation, Neoplastic; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; L-Lactate Dehydrogenase; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Retrospective Studies; Risk Factors; Rituximab; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Vincristine; Waldenstrom Macroglobulinemia | 2017 |
Noninvasive
Topics: Animals; Biological Transport; Cell Line, Tumor; Cell Transformation, Neoplastic; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Mice; Positron-Emission Tomography; Proto-Oncogene Proteins c-myc; Radioisotopes; Transferrin; Triple Negative Breast Neoplasms; Zirconium | 2018 |
Lymphangiosarcoma of the hip arising in a congenital non-irradiated lymphangioma.
Topics: Adult; Biopsy; Cell Transformation, Neoplastic; Fatal Outcome; Female; Fluorodeoxyglucose F18; Hip; Humans; Lymphangioma; Lymphangiosarcoma; Neoplasms, Second Primary; Positron-Emission Tomography; Retroperitoneal Neoplasms; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2017 |
Richter Syndrome Presenting With Colon Localization.
Topics: Aged; Biopsy; Cell Transformation, Neoplastic; Colon; Fluorodeoxyglucose F18; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Positron Emission Tomography Computed Tomography | 2019 |
Measurement of 18F-FDG PET tumor heterogeneity improves early assessment of response to bevacizumab compared with the standard size and uptake metrics in a colorectal cancer model.
Topics: Animals; Bevacizumab; Biological Transport; Cell Transformation, Neoplastic; Colorectal Neoplasms; Disease Models, Animal; Fluorodeoxyglucose F18; Mice; Positron Emission Tomography Computed Tomography; Time Factors; Treatment Outcome; Tumor Burden | 2019 |
Can 18F-FDG PET/CT diagnose malignant change in benign chondroid tumors?
Topics: Adolescent; Adult; Aged; Cell Transformation, Neoplastic; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Connective Tissue; Positron Emission Tomography Computed Tomography; Young Adult | 2019 |
Comprehensive molecular imaging of malignant transformation of giant cell tumour of bone reveals diverse disease biology.
Topics: Adult; Bone Neoplasms; Cell Transformation, Neoplastic; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Giant Cell Tumor of Bone; Humans; Molecular Imaging; Neoplasm Metastasis; Osteosarcoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rare Diseases; Sodium Fluoride; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2019 |
Antilipolytic drug boosts glucose metabolism in prostate cancer.
Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Glucose; Humans; Hypolipidemic Agents; Male; Mice; Mice, Nude; Positron-Emission Tomography; Prostatic Neoplasms; Pyrazines; Tissue Distribution | 2013 |
Monitoring afatinib treatment in HER2-positive gastric cancer with 18F-FDG and 89Zr-trastuzumab PET.
Topics: Afatinib; Animals; Antibodies, Monoclonal, Humanized; Cell Line, Tumor; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Humans; Mice; Positron-Emission Tomography; Protein Kinase Inhibitors; Quinazolines; Radiochemistry; Receptor, ErbB-2; Stomach Neoplasms; Treatment Outcome | 2013 |
Correlation between ¹⁸F-FDG uptake and the expression of glucose transporter-1 and hypoxia-inducible factor-1α in transplanted VX2 tumors.
Topics: Animals; Biological Transport; Cell Line, Tumor; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Rabbits; Tomography, X-Ray Computed; Tumor Burden | 2013 |
Transformation of follicular lymphoma in the retroperitoneal muscles demonstrated by CT-guided needle biopsy of FDG-avid lesions; case series.
Topics: Aged; Cell Transformation, Neoplastic; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Multimodal Imaging; Muscle, Skeletal; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Utility of 18F-FDG PET with a semi-quantitative index in the detection of sarcomatous transformation in patients with neurofibromatosis type 1.
Topics: Adolescent; Adult; Aged; Cell Transformation, Neoplastic; Child; Child, Preschool; Demography; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Neurofibromatosis 1; Positron-Emission Tomography; Sarcoma | 2014 |
Impact of initial FDG-PET/CT and serum-free light chain on transformation of conventionally defined solitary plasmacytoma to multiple myeloma.
Topics: Aged; Biomarkers, Tumor; Bone Neoplasms; Cell Transformation, Neoplastic; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Immunoglobulin Light Chains; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; Plasmacytoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2014 |
The usefulness of preoperative 18FDG positron-emission tomography and computed tomography for predicting the malignant potential of gastrointestinal stromal tumors.
Topics: Adult; Aged; Aged, 80 and over; Cell Transformation, Neoplastic; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Ki-67 Antigen; Male; Middle Aged; Mitotic Index; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Tumor Burden | 2014 |
Variability of Proliferation and Diffusion in Different Lung Cancer Models as Measured by 3'-Deoxy-3'-¹⁸F-Fluorothymidine PET and Diffusion-Weighted MR Imaging.
Topics: Animals; Biological Transport; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Dideoxynucleosides; Diffusion; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Kinetics; Lung Neoplasms; Mice; Positron-Emission Tomography | 2014 |
Comparison of intratumoral FDG and Cu-ATSM distributions in cancer tissue originated spheroid (CTOS) xenografts, a tumor model retaining the original tumor properties.
Topics: Adenocarcinoma; Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Transformation, Neoplastic; Colonic Neoplasms; Coordination Complexes; Fluorodeoxyglucose F18; Mice; Organometallic Compounds; Spheroids, Cellular; Thiosemicarbazones | 2014 |
(68)Ga-AMBA and (18)F-FDG for preclinical PET imaging of breast cancer: effect of tamoxifen treatment on tracer uptake by tumor.
Topics: Animals; Biological Transport; Breast Neoplasms; Cell Proliferation; Cell Transformation, Neoplastic; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Mice; Oligopeptides; Positron-Emission Tomography; Tamoxifen; Tumor Burden | 2015 |
18F-FDG PET/CT findings of a recurrent adenocarcinoma arising from malignant transformation of abdominal wall endometriosis.
Topics: Abdominal Wall; Adenocarcinoma; Adult; Cell Transformation, Neoplastic; Endometrial Neoplasms; Endometriosis; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Malignant transformation of a lacrimal gland pleomorphic adenoma with pulmonary metastases.
Topics: Adenoma, Pleomorphic; Aged; Carcinoma, Adenoid Cystic; Cell Transformation, Neoplastic; Eye Neoplasms; Fluorodeoxyglucose F18; Humans; Lacrimal Apparatus Diseases; Lung Neoplasms; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Utility of respiratory-gated small-animal PET/CT in the chronologic evaluation of an orthotopic lung cancer transplantation mouse model.
Topics: Animals; Biological Transport; Cell Line, Tumor; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mice; Movement; Multimodal Imaging; Positron-Emission Tomography; Respiration; Respiratory-Gated Imaging Techniques; Time Factors; Tomography, X-Ray Computed; Tumor Burden | 2015 |
Ex-vivo biodistribution and micro-PET/CT imaging of 18F-FDG, 18F-FLT, 18F-FMISO, and 18F-AlF-NOTA-PRGD2 in a prostate tumor-bearing nude mouse model.
Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Dideoxynucleosides; Disease Models, Animal; Fluorodeoxyglucose F18; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Male; Mice; Mice, Nude; Misonidazole; Multimodal Imaging; Oligopeptides; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed | 2015 |
Evaluation of the therapeutic efficacy of a MEK inhibitor (TAK-733) using ¹⁸F-fluorodeoxyglucose-positron emission tomography in the human lung xenograft model A549.
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Transformation, Neoplastic; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mitogen-Activated Protein Kinase Kinases; Positron-Emission Tomography; Protein Kinase Inhibitors; Pyridones; Pyrimidinones; Rats; Treatment Outcome | 2015 |
A Case Report of High 18F-FDG PET/CT Uptake in Progressive Transformation of the Germinal Centers.
Topics: Aged; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Lymphoma; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Spontaneous regression of interdigitating dendritic sarcoma in a patient with concurrent small lymphocytic lymphoma.
Topics: Cell Transformation, Neoplastic; Dendritic Cell Sarcoma, Interdigitating; Fever; Fluorodeoxyglucose F18; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Remission, Spontaneous; Tomography, X-Ray Computed; Treatment Outcome; Weight Loss | 2015 |
Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients.
Topics: Adolescent; Adult; Biopsy; Cell Transformation, Neoplastic; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nerve Sheath Neoplasms; Neurofibromatosis 1; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2015 |
Teratocarcinomas Arising from Allogeneic Induced Pluripotent Stem Cell-Derived Cardiac Tissue Constructs Provoked Host Immune Rejection in Mice.
Topics: Animals; Biopsy; Cell Line; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Gene Order; Genetic Vectors; Graft Rejection; Immunocompromised Host; Immunosuppressive Agents; Induced Pluripotent Stem Cells; Male; Mice; Mice, Transgenic; Models, Animal; Myocytes, Cardiac; Positron-Emission Tomography; Stem Cell Transplantation; T-Lymphocyte Subsets; Tacrolimus; Teratocarcinoma; Transplantation, Homologous | 2016 |
Metabolic Tumour Burden Measured by 18F-FDG PET/CT Predicts Malignant Transformation in Patients with Neurofibromatosis Type-1.
Topics: Adolescent; Adult; Cell Transformation, Neoplastic; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurofibromatosis 1; Prognosis; Radionuclide Imaging; Retrospective Studies; Sarcoma; Survival Rate; Tumor Burden; Young Adult | 2016 |
False Suggestion of Malignant Transformation of Benign Bone Tumor by 18F-FDG PET/CT: A Potential Pitfall.
Topics: Bone Neoplasms; Cell Transformation, Neoplastic; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography | 2016 |
Primary cutaneous plasmacytoma.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bortezomib; Cell Transformation, Neoplastic; Cyclophosphamide; Dexamethasone; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gene Rearrangement; Humans; Immunoglobulin Heavy Chains; Immunoglobulin M; Middle Aged; Multiple Myeloma; Plasma Cells; Positron-Emission Tomography; Proto-Oncogene Proteins c-bcl-6; Radiopharmaceuticals; Skin Neoplasms; Treatment Outcome | 2017 |
F-18 fluorodeoxyglucose (FDG) PET in the diagnosis of malignant transformation of fibrous dysplasia in the pelvic bones.
Topics: Bone and Bones; Cell Proliferation; Cell Transformation, Neoplastic; Fatal Outcome; Female; Fibrous Dysplasia of Bone; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma | 2008 |
Integrated PET/CT in evaluating sarcomatous transformation in osteochondromas.
Topics: Adolescent; Adult; Cell Transformation, Neoplastic; Exostoses; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Osteochondroma; Pelvic Pain; Positron-Emission Tomography; Sarcoma; Tomography, X-Ray Computed | 2009 |
18F-FDG small-animal PET/CT differentiates trastuzumab-responsive from unresponsive human breast cancer xenografts in athymic mice.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Breast Neoplasms; Cell Line, Tumor; Cell Transformation, Neoplastic; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Genes, erbB-2; Humans; Immunohistochemistry; Mice; Mice, Nude; Positron-Emission Tomography; Sensitivity and Specificity; Tissue Distribution; Tomography, X-Ray Computed; Trastuzumab; Treatment Outcome | 2009 |
PTEN dosage is essential for neurofibroma development and malignant transformation.
Topics: Animals; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Gene Dosage; Humans; Mice; Mice, Mutant Strains; Mitogen-Activated Protein Kinase Kinases; Neurofibroma; Oncogene Protein p21(ras); Positron-Emission Tomography; PTEN Phosphohydrolase; raf Kinases | 2009 |
Histological transformation of follicular lymphoma after treatment: a case evaluated with PET/CT.
Topics: Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
High-contrast PET of melanoma using (18)F-MEL050, a selective probe for melanin with predominantly renal clearance.
Topics: Animals; Autoradiography; Cell Line, Tumor; Cell Transformation, Neoplastic; Contrast Media; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Kidney; Melanins; Melanoma; Mice; Neoplasm Metastasis; Niacinamide; Positron-Emission Tomography; Pyridines; Substrate Specificity; Tomography, X-Ray Computed; Transplantation, Homologous; Whole Body Imaging | 2010 |
Malignant transformation in an area with elevated F-18 FDG uptake within a low metabolic benign neurofibroma.
Topics: Cell Transformation, Neoplastic; False Negative Reactions; Fluorodeoxyglucose F18; Humans; Male; Neurofibroma; Positron-Emission Tomography; Radiopharmaceuticals; Spinal Neoplasms; Young Adult | 2010 |
Increased 18F-FDG uptake and expression of Glut1 in the EMT transformed breast cancer cells induced by TGF-beta.
Topics: Breast Neoplasms; Cadherins; Cell Line, Tumor; Cell Movement; Cell Transformation, Neoplastic; Epithelial Cells; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Mesoderm; Radiopharmaceuticals; Transforming Growth Factor beta; Vimentin | 2010 |
False positive FDG-PET extensive diffuse abdominal tracer activity in a patient with CLL on whole-body 18FDG-PET/CT indicative of Ritcher's transformation.
Topics: Abdomen; Cell Transformation, Neoplastic; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Positron-Emission Tomography; Radiography, Abdominal; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
PET imaging of inflammation and adenocarcinoma xenografts using vascular adhesion protein 1 targeting peptide 68Ga-DOTAVAP-P1: comparison with 18F-FDG.
Topics: Adenocarcinoma; Amine Oxidase (Copper-Containing); Animals; Cell Adhesion Molecules; Cell Line, Tumor; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 1-Ring; Humans; Inflammation; Male; Pancreatic Neoplasms; Peptides; Positron-Emission Tomography; Rats; Skin Diseases | 2010 |
αvβ3 imaging can accurately distinguish between mature teratoma and necrosis in 18F-FDG-negative residual masses after treatment of non-seminomatous testicular cancer: a preclinical study.
Topics: Animals; Cell Differentiation; Cell Line, Tumor; Cell Transformation, Neoplastic; Cisplatin; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Integrin alphaVbeta3; Male; Molecular Imaging; Necrosis; Neoplasm, Residual; Rats; Teratoma; Testicular Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Tretinoin | 2011 |
Renal metastases from thyroid carcinoma.
Topics: Adenoma, Oxyphilic; Carcinoma; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Kidney Neoplasms; Positron-Emission Tomography; Quality of Life; Thyroid Neoplasms | 2010 |
Malignant transformation to schwannoma in a patient affected by type 1 neurofibromatosis as demonstrated by F-18-FDG-PET/CT.
Topics: Aged; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Humans; Male; Neurilemmoma; Neurofibromatosis 1; Positron-Emission Tomography; Tomography, X-Ray Computed | 2010 |
Features of large cell transformation of indolent lymphomas as observed on sequential PET/CT.
Topics: Biological Transport; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Humans; Lymphoma, Non-Hodgkin; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2011 |
Evaluation of 4-[18F]fluorobenzoyl-FALGEA-NH2 as a positron emission tomography tracer for epidermal growth factor receptor mutation variant III imaging in cancer.
Topics: Animals; Benzoates; Biological Transport; Cell Transformation, Neoplastic; Drug Stability; ErbB Receptors; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Mice; Mutation; Oligopeptides; Positron-Emission Tomography; Radioactive Tracers | 2011 |
Recent progress in carcinogenesis, progression and therapy of breast cancer: the 20th Hiroshima Cancer Seminar--the 4th Three Universities' Consortium International Symposium, October 2010: 31 October 2010, International Conference Center Hiroshima.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Biomarkers, Tumor; Breast Neoplasms; Cell Transformation, Neoplastic; Cost-Benefit Analysis; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinase Inhibitor p16; Disease Progression; Drug Resistance, Neoplasm; Estrogens; Female; Fluorodeoxyglucose F18; Hexosyltransferases; Humans; Insurance Coverage; International Cooperation; Membrane Proteins; MicroRNAs; Molecular Targeted Therapy; Neoplasm Proteins; Positron-Emission Tomography; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Receptor, ErbB-2; Receptors, Immunologic; Signal Transduction; Sirtuin 1; Universities | 2011 |
Progressive transformation of germinal centers in a pediatric patient: initial evaluation and follow-up with serial F-18 FDG PET/CT imaging.
Topics: Adolescent; Cell Transformation, Neoplastic; DiGeorge Syndrome; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoma; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
Multimodal imaging with (18)F-FDG PET and Cerenkov luminescence imaging after MLN4924 treatment in a human lymphoma xenograft model.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Transformation, Neoplastic; Cyclopentanes; Female; Fluorodeoxyglucose F18; Humans; Luminescent Measurements; Lymphoma; Mice; Molecular Imaging; Positron-Emission Tomography; Pyrimidines | 2011 |
Risk stratification of gallbladder polyps (1-2 cm) for surgical intervention with 18F-FDG PET/CT.
Topics: Adenocarcinoma; Adenoma; Adult; Aged; Cell Transformation, Neoplastic; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gallbladder Diseases; Gallbladder Neoplasms; Gallstones; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Polyps; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; ROC Curve; Tomography, Emission-Computed | 2012 |
[18F]-Fluorodeoxyglucose positron emission tomography in children with neurofibromatosis type 1 and plexiform neurofibromas: correlation with malignant transformation.
Topics: Adolescent; Adult; Cell Transformation, Neoplastic; Child; Child, Preschool; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Infant; Male; Nerve Sheath Neoplasms; Neurofibroma, Plexiform; Neurofibromatosis 1; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Young Adult | 2012 |
Malignant transformation of retroperitoneal inflammatory pseudotumor to undifferentiated high-grade pleomorphic sarcoma on FDG PET/CT.
Topics: Aged; Cell Differentiation; Cell Transformation, Neoplastic; Female; Fluorodeoxyglucose F18; Granuloma, Plasma Cell; Humans; Multimodal Imaging; Neoplasm Grading; Positron-Emission Tomography; Retroperitoneal Neoplasms; Sarcoma; Tomography, X-Ray Computed | 2012 |
Comparison of 2-amino-[3-¹¹C]isobutyric acid and 2-deoxy-2-[¹⁸F]fluoro-D-glucose in nude mice with xenografted tumors and acute inflammation.
Topics: Acute Disease; Aminoisobutyric Acids; Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Drug Stability; Fluorodeoxyglucose F18; Humans; Inflammation; Lung Neoplasms; Male; Mice; Mice, Nude; Positron-Emission Tomography; Small Cell Lung Carcinoma | 2012 |
Richter's syndrome: Utility of ¹⁸F-FDG PET/CT.
Topics: Aged; Cell Transformation, Neoplastic; Female; Fluorodeoxyglucose F18; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Syndrome; Tomography, X-Ray Computed | 2013 |
FDG-PET/CT findings of sarcomatous transformation in neurofibromatosis: a case report.
Topics: Adult; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Humans; Male; Neurofibromatoses; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
Potential clinical role of FDG-PET in detecting sarcomatous transformation in von Recklinghausen's disease: a case study and review of the literature.
Topics: Adult; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neurofibromatosis 1; Positron-Emission Tomography; Sarcoma | 2006 |
PET positive progressive transformation of germinal centers masquerading as relapsed Hodgkin lymphoma post-autograft.
Topics: Cell Transformation, Neoplastic; Diagnosis, Differential; Fluorodeoxyglucose F18; Germinal Center; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Remission Induction; Transplantation, Autologous | 2006 |
Somatic malignant transformation in a sacrococcygeal teratoma in a child and the use of F18FDG PET imaging.
Topics: Adenocarcinoma; Cell Transformation, Neoplastic; Child; Female; Fluorodeoxyglucose F18; Humans; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sacrococcygeal Region; Teratoma; Treatment Outcome | 2008 |
[Utility of 18 FDG positon emission tomography in detection of sarcomatous transformation in neurofibromatosis type 1].
Topics: Adolescent; Adult; Aged; Cell Transformation, Neoplastic; Child; Decision Trees; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurofibromatosis 1; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma | 2007 |
Accurate grading of 3 synchronous liposarcomas assessed by PET-CT in a single patient.
Topics: Biomarkers, Tumor; Cell Transformation, Neoplastic; Contrast Media; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Liposarcoma; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Retroperitoneal Neoplasms; Tomography, X-Ray Computed | 2007 |
Differential uptake of 2-fluoro-2-deoxyglucose by normal and transformed chicken and mouse fibroblasts as a function of glucose concentration.
Topics: Animals; Carbon Radioisotopes; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Chick Embryo; Deoxy Sugars; Deoxyglucose; Fibroblasts; Fluorodeoxyglucose F18; Glucose; Mice | 1982 |
Adenocarcinoma of a foregut cyst: detection with positron emission tomography.
Topics: Adenocarcinoma, Mucinous; Adult; Cell Transformation, Neoplastic; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Lymphatic Metastasis; Mediastinal Cyst; Mediastinal Neoplasms; Tomography, Emission-Computed | 1996 |
Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study.
Topics: Adult; Aged; Aspartic Acid; Biomarkers, Tumor; Biopsy; Brain Neoplasms; Cell Transformation, Neoplastic; Choline; Creatine; Deoxyglucose; Disease Progression; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Hydrogen; Lactic Acid; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Recurrence, Local; Phosphocreatine; Prognosis; Protons; Radiopharmaceuticals; Tomography, Emission-Computed | 1997 |
Discordant Tc-99m depreotide and F-18 FDG imaging in a patient with poorly differentiated small-cell neuroendocrine carcinoma.
Topics: Aged; Aged, 80 and over; Biopsy; Carcinoma, Small Cell; Cell Transformation, Neoplastic; Diagnosis, Differential; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Organotechnetium Compounds; Radiopharmaceuticals; Somatostatin; Tomography, X-Ray Computed | 2002 |